加拿大安大略省轮状病毒免疫规划实施前后流行的轮状病毒基因型
研究监测了加拿大安大略省2011年8月引入公开资助的单价轮状病毒免疫规划前后轮状病毒A型(RVA)的检出率和基因型。实施规划后RVA阳性率从14.4%降至6.1%,但基因分型标本中G10型比例从6.3%升至31.5%,作者认为持续监测对评估免疫长期影响和基因型出现很重要。
要点
- 免疫规划实施后RVA阳性率由14.4%(1537/10700)降至6.1%(548/9019)。
- 基因分型标本中G10型比例由6.3%(13/205)升至31.5%(40/127)。
- 文献综述检索到来自16个国家的约200份G10阳性人粪便标本。
核心结论
- 研究记录到免疫规划实施后RVA阳性标本数和阳性率下降,但检测到G10型比例出现非预期上升。
- 作者认为持续开展RVA监测对于评估免疫规划的长期影响和RVA基因型的出现很重要。
研究设计与样本
- 在加拿大安大略省公共卫生实验室开展RVA检测,涵盖2009年1月至2011年12月的规划前时期和2012年1月至2015年10月的公开资助RVA免疫规划时期,分析RVA阳性标本数和阳性率。
- 对2010年9月至2011年12月规划前时期和2012年1月至2013年6月规划时期的RVA阳性粪便标本便利样本,采用半巢式PCR进行基因分型。
- 进行了一项关于新出现基因型疾病负担的文献综述。
主要发现
- RVA阳性率从36个月规划前时期的14.4%(1537/10700)显著下降至46个月规划时期的6.1%(548/9019)。
- 基因分型标本中G10型比例从规划前时期的6.3%(13/205)上升至规划时期的31.5%(40/127),G10与五种不同P基因型相关。
- 文献综述识别出来自16个不同国家的约200份G10阳性人粪便标本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Ontario introduced a universal publicly-funded group A rotavirus (RVA) immunization program in August 2011, using monovalent vaccine. RVA immunization programs have decreased the incidence of RVA acute gastroenteritis in many countries but it is unclear if it will contribute to the emergence of certain genotypes. We monitored RVA trends and genotypes in Ontario before and after implementation of the publicly-funded immunization program. METHODS: RVA detection was conducted at Public Health Ontario Laboratories from January 2009 to December 2011 (pre-program period) and January 2012 to October 2015 (publicly-funded RVA immunization program period) and number of RVA-positive specimens and percent positivity were analysed. A convenience sample of RVA-positive stool specimens, from September 2010 to December 2011 (pre-program period) and January 2012 to June 2013 (program period), were genotyped using heminested PCR. A literature review on the burden of illness from emergent genotype was performed. RESULTS: Stool specimens showed a significant decrease in RVA percent positivity from the 36 month pre-program period (14.4%; 1537/10700) to the 46 month program period (6.1%; 548/9019). An increase in the proportion of RVA G10 among genotyped specimens, associated with five different P genotypes, from the pre-program (6.3%; 13/205) to the program (31.5%; 40/127) period was observed. Our literature review identified approximately 200 G10-positive human stool specimens from 16 different countries. CONCLUSIONS: This study documented a decrease in the number of RVA-positive specimens and percent positivity after implementation of the immunization program. An unexpected increase in the proportion of RVA G10 was detected following program introduction. Ongoing RVA surveillance is important in evaluating both the long-term impact of immunization and emergence of RVA genotypes.
引用
- Isabel S, Higgins RR, Peci A, et al. Rotavirus genotypes circulating in Ontario, Canada, before and after implementation of the rotavirus immunization program. Vaccine. 2018. PMID: 29526372. doi:10.1016/j.vaccine.2018.02.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。